Compounds > ifosfamide
Page last updated: 2024-10-29

ifosfamide and Basal Ganglia Diseases

ifosfamide has been researched along with Basal Ganglia Diseases in 2 studies

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pallotta, MG1
Velazco, A1
Sadler, A1
Anderson, NR1
Tandon, DS1

Other Studies

2 other studies available for ifosfamide and Basal Ganglia Diseases

ArticleYear
Ifosfamide extrapyramidal neurotoxicity.
    Cancer, 1992, Dec-01, Volume: 70, Issue:11

    Topics: Adolescent; Adult; Basal Ganglia Diseases; Extrapyramidal Tracts; Female; Humans; Ifosfamide; Male

1992
Ifosfamide extrapyramidal neurotoxicity.
    Cancer, 1991, Jul-01, Volume: 68, Issue:1

    Topics: Adenocarcinoma; Basal Ganglia Diseases; Humans; Ifosfamide; Lung Neoplasms; Lymphoma, Large B-Cell,

1991